0 XP   0   0   0

GODAVARI DRUGS LTD.
Buy, Hold or Sell?

Should you buy, hold or sell GODAVARI DRUGS LTD.?

I guess you are interested in GODAVARI DRUGS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse GODAVARI DRUGS LTD.

Let's start. I'm going to help you getting a better view of GODAVARI DRUGS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is GODAVARI DRUGS LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how GODAVARI DRUGS LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value GODAVARI DRUGS LTD.. The closing price on 2023-01-25 was INR89.05 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
GODAVARI DRUGS LTD. Daily Candlestick Chart
GODAVARI DRUGS LTD. Daily Candlestick Chart
Summary









1. Valuation of GODAVARI DRUGS LTD.




Current price per share

INR89.05

2. Growth of GODAVARI DRUGS LTD.




Is GODAVARI DRUGS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$3.6m$2.9m$645.1k17.7%

How much money is GODAVARI DRUGS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$645.1k$507.7k$137.4k21.3%
Net Profit Margin3.3%3.4%--

How much money comes from the company's main activities?

3. Financial Health of GODAVARI DRUGS LTD.




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  


Richest
#403 / 705

Most Revenue
#182 / 705

Most Profit
#223 / 705

Most Efficient
#307 / 705


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

1.1. Profitability of GODAVARI DRUGS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit GODAVARI DRUGS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare GODAVARI DRUGS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of 3.3% means that ₹0.03 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GODAVARI DRUGS LTD.:

  • The MRQ is 3.3%. The company is making a profit. +1
  • The TTM is 3.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.3%TTM3.3%0.0%
TTM3.3%YOY3.4%-0.1%
TTM3.3%5Y2.3%+1.0%
5Y2.3%10Y4.5%-2.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3%0.4%+2.9%
TTM3.3%0.3%+3.0%
YOY3.4%0.2%+3.2%
5Y2.3%-0.7%+3.0%
10Y4.5%-0.1%+4.6%
1.1.2. Return on Assets

Shows how efficient GODAVARI DRUGS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare GODAVARI DRUGS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • 5.2% Return on Assets means that GODAVARI DRUGS LTD. generated ₹0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GODAVARI DRUGS LTD.:

  • The MRQ is 5.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.2%TTM5.2%0.0%
TTM5.2%YOY4.5%+0.6%
TTM5.2%5Y3.0%+2.2%
5Y3.0%10Y4.5%-1.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2%0.1%+5.1%
TTM5.2%0.1%+5.1%
YOY4.5%-0.1%+4.6%
5Y3.0%-0.2%+3.2%
10Y4.5%0.1%+4.4%
1.1.3. Return on Equity

Shows how efficient GODAVARI DRUGS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare GODAVARI DRUGS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • 17.7% Return on Equity means GODAVARI DRUGS LTD. generated ₹0.18 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GODAVARI DRUGS LTD.:

  • The MRQ is 17.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 17.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.7%TTM17.7%0.0%
TTM17.7%YOY16.9%+0.8%
TTM17.7%5Y11.2%+6.5%
5Y11.2%10Y12.1%-0.9%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ17.7%0.6%+17.1%
TTM17.7%0.4%+17.3%
YOY16.9%0.4%+16.5%
5Y11.2%-0.3%+11.5%
10Y12.1%0.1%+12.0%

1.2. Operating Efficiency of GODAVARI DRUGS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient GODAVARI DRUGS LTD. is operating .

  • Measures how much profit GODAVARI DRUGS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare GODAVARI DRUGS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GODAVARI DRUGS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y3.1%-3.1%
5Y3.1%10Y5.5%-2.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.5%-2.5%
TTM-1.6%-1.6%
YOY-2.7%-2.7%
5Y3.1%1.8%+1.3%
10Y5.5%0.8%+4.7%
1.2.2. Operating Ratio

Measures how efficient GODAVARI DRUGS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 1.75 means that the operating costs are ₹1.75 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 1.750. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.750. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.750TTM1.7500.000
TTM1.750YOY1.717+0.033
TTM1.7505Y1.732+0.018
5Y1.73210Y1.655+0.077
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7501.473+0.277
TTM1.7501.456+0.294
YOY1.7171.398+0.319
5Y1.7321.374+0.358
10Y1.6551.191+0.464

1.3. Liquidity of GODAVARI DRUGS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if GODAVARI DRUGS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 1.29 means the company has ₹1.29 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 1.287. The company is just able to pay all its short-term debts.
  • The TTM is 1.287. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.287TTM1.2870.000
TTM1.287YOY1.339-0.052
TTM1.2875Y1.260+0.027
5Y1.26010Y1.435-0.175
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2871.880-0.593
TTM1.2871.901-0.614
YOY1.3392.112-0.773
5Y1.2602.182-0.922
10Y1.4351.891-0.456
1.3.2. Quick Ratio

Measures if GODAVARI DRUGS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare GODAVARI DRUGS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 1.00 means the company can pay off ₹1.00 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 1.002. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.002. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.002TTM1.0020.000
TTM1.002YOY0.926+0.076
TTM1.0025Y0.847+0.154
5Y0.84710Y0.812+0.035
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0020.733+0.269
TTM1.0020.796+0.206
YOY0.9260.808+0.118
5Y0.8470.834+0.013
10Y0.8120.821-0.009

1.4. Solvency of GODAVARI DRUGS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of GODAVARI DRUGS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare GODAVARI DRUGS LTD. to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.71 means that GODAVARI DRUGS LTD. assets are financed with 70.8% credit (debt) and the remaining percentage (100% - 70.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 0.708. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.708. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.708TTM0.7080.000
TTM0.708YOY0.732-0.025
TTM0.7085Y0.737-0.029
5Y0.73710Y0.657+0.079
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7080.437+0.271
TTM0.7080.424+0.284
YOY0.7320.398+0.334
5Y0.7370.398+0.339
10Y0.6570.401+0.256
1.4.2. Debt to Equity Ratio

Measures if GODAVARI DRUGS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare GODAVARI DRUGS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 242.2% means that company has ₹2.42 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 2.422. The company is just not able to pay all its debts with equity.
  • The TTM is 2.422. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.422TTM2.4220.000
TTM2.422YOY2.737-0.315
TTM2.4225Y2.817-0.395
5Y2.81710Y2.129+0.688
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4220.652+1.770
TTM2.4220.675+1.747
YOY2.7370.623+2.114
5Y2.8170.684+2.133
10Y2.1290.697+1.432

2. Market Valuation of GODAVARI DRUGS LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings GODAVARI DRUGS LTD. generates.

  • Above 15 is considered overpriced but always compare GODAVARI DRUGS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of 9.39 means the investor is paying ₹9.39 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GODAVARI DRUGS LTD.:

  • The EOD is 12.785. Very good. +2
  • The MRQ is 9.389. Very good. +2
  • The TTM is 9.389. Very good. +2
Trends
Current periodCompared to+/- 
EOD12.785MRQ9.389+3.395
MRQ9.389TTM9.3890.000
TTM9.389YOY8.346+1.043
TTM9.3895Y12.934-3.545
5Y12.93410Y13.009-0.075
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD12.785-0.124+12.909
MRQ9.389-0.437+9.826
TTM9.389-0.102+9.491
YOY8.34615.340-6.994
5Y12.9347.916+5.018
10Y13.0097.700+5.309
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of GODAVARI DRUGS LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 7.389. Seems overpriced? -1
  • The TTM is 7.389. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ7.389TTM7.3890.000
TTM7.389YOY4.045+3.344
TTM7.3895Y17.237-9.848
5Y17.23710Y18.004-0.767
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3890.012+7.377
TTM7.3890.010+7.379
YOY4.0450.004+4.041
5Y17.2370.010+17.227
10Y18.0040.021+17.983

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of GODAVARI DRUGS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 1.66 means the investor is paying ₹1.66 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of GODAVARI DRUGS LTD.:

  • The EOD is 2.263. Good. +1
  • The MRQ is 1.662. Good. +1
  • The TTM is 1.662. Good. +1
Trends
Current periodCompared to+/- 
EOD2.263MRQ1.662+0.601
MRQ1.662TTM1.6620.000
TTM1.662YOY1.413+0.249
TTM1.6625Y1.164+0.498
5Y1.16410Y1.425-0.261
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD2.2631.415+0.848
MRQ1.6621.586+0.076
TTM1.6622.019-0.357
YOY1.4132.230-0.817
5Y1.1641.895-0.731
10Y1.4251.505-0.080
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of GODAVARI DRUGS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--6.9656.9650%5.482+27%3.562+96%3.935+77%
Book Value Growth--1.2151.2150%1.204+1%1.130+8%1.160+5%
Book Value Per Share--39.34939.3490%32.383+22%29.103+35%22.678+74%
Book Value Per Share Growth--1.2151.2150%1.204+1%1.130+8%1.160+5%
Current Ratio--1.2871.2870%1.339-4%1.260+2%1.435-10%
Debt To Asset Ratio--0.7080.7080%0.732-3%0.737-4%0.657+8%
Debt To Equity Ratio--2.4222.4220%2.737-12%2.817-14%2.129+14%
Dividend Per Share----0%-0%-0%0.000-100%
Eps--6.9656.9650%5.482+27%3.562+96%2.957+136%
Eps Growth--1.2711.2710%2.063-38%1.381-8%1.563-19%
Free Cash Flow Per Share--7.9477.9470%-0.457+106%1.679+373%-0.718+109%
Free Cash Flow Per Share Growth--19.38719.3870%1.467+1221%5.230+271%-12.212+163%
Free Cash Flow To Equity Per Share--0.4830.4830%-0.279+158%-0.115+124%-0.070+114%
Free Cash Flow To Equity Per Share Growth--3.7303.7300%1.319+183%0.459+712%3.963-6%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--404.570--------
Intrinsic Value_10Y_min--336.111--------
Intrinsic Value_1Y_max--15.008--------
Intrinsic Value_1Y_min--14.583--------
Intrinsic Value_3Y_max--64.552--------
Intrinsic Value_3Y_min--60.617--------
Intrinsic Value_5Y_max--137.556--------
Intrinsic Value_5Y_min--124.710--------
Net Profit Margin--0.0330.0330%0.034-3%0.023+42%0.045-27%
Operating Margin----0%-0%0.031-100%0.055-100%
Operating Ratio--1.7501.7500%1.717+2%1.732+1%1.655+6%
Pb Ratio2.263+27%1.6621.6620%1.413+18%1.164+43%1.425+17%
Pe Ratio12.785+27%9.3899.3890%8.346+13%12.934-27%13.009-28%
Peg Ratio--7.3897.3890%4.045+83%17.237-57%18.004-59%
Price Per Share89.050+27%65.40065.4000%45.750+43%35.320+85%32.473+101%
Price To Total Gains Ratio12.785+27%9.3899.3890%8.346+13%12.934-27%11.909-21%
Profit Growth--1.2711.2710%2.063-38%1.381-8%1.563-19%
Quick Ratio--1.0021.0020%0.926+8%0.847+18%0.812+23%
Return On Assets--0.0520.0520%0.045+14%0.030+72%0.045+15%
Return On Equity--0.1770.1770%0.169+5%0.112+58%0.121+47%
Revenue Growth--1.3131.3130%1.282+2%1.178+11%1.698-23%
Total Gains Per Share--6.9656.9650%5.482+27%3.562+96%3.935+77%
Total Gains Per Share Growth--1.2711.2710%2.063-38%1.381-8%1.241+2%
Usd Book Value--3644662.2003644662.2000%2999494.482+22%2695710.164+35%2100583.406+74%
Usd Book Value Change Per Share--0.0860.0860%0.067+27%0.044+96%0.048+77%
Usd Book Value Per Share--0.4840.4840%0.398+22%0.358+35%0.279+74%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps--0.0860.0860%0.067+27%0.044+96%0.036+136%
Usd Free Cash Flow--736118.100736118.1000%-42336.600+106%155496.600+373%77748.300+847%
Usd Free Cash Flow Per Share--0.0980.0980%-0.006+106%0.021+373%-0.009+109%
Usd Free Cash Flow To Equity Per Share--0.0060.0060%-0.003+158%-0.001+124%-0.001+114%
Usd Price Per Share1.095+27%0.8040.8040%0.563+43%0.434+85%0.399+101%
Usd Profit--645171.900645171.9000%507752.979+27%329934.560+96%273930.243+136%
Usd Revenue--19816065.06019816065.0600%15088429.434+31%12975664.412+53%9281244.885+114%
Usd Total Gains Per Share--0.0860.0860%0.067+27%0.044+96%0.048+77%
 EOD+2 -3MRQTTM+0 -0YOY+28 -105Y+31 -810Y+26 -15

3.2. Fundamental Score

Let's check the fundamental score of GODAVARI DRUGS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.785
Price to Book Ratio (EOD)Between0-12.263
Net Profit Margin (MRQ)Greater than00.033
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.002
Current Ratio (MRQ)Greater than11.287
Debt to Asset Ratio (MRQ)Less than10.708
Debt to Equity Ratio (MRQ)Less than12.422
Return on Equity (MRQ)Greater than0.150.177
Return on Assets (MRQ)Greater than0.050.052
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of GODAVARI DRUGS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose90.950
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,014,110
Total Liabilities717,796
Total Stockholder Equity296,314
 As reported
Total Liabilities 717,796
Total Stockholder Equity+ 296,314
Total Assets = 1,014,110

Assets

Total Assets1,014,110
Total Current Assets743,342
Long-term Assets743,342
Total Current Assets
Cash And Cash Equivalents 29
Net Receivables 555,790
Inventory 100,337
Other Current Assets 58,364
Total Current Assets  (as reported)743,342
Total Current Assets  (calculated)714,520
+/- 28,822
Long-term Assets
Property Plant Equipment 267,411
Other Assets 3,356
Long-term Assets  (as reported)271,073
Long-term Assets  (calculated)270,767
+/- 306

Liabilities & Shareholders' Equity

Total Current Liabilities577,610
Long-term Liabilities140,187
Total Stockholder Equity296,314
Total Current Liabilities
Short-term Debt 85,612
Short Long Term Debt 112,903
Accounts payable 433,169
Other Current Liabilities 3,189
Total Current Liabilities  (as reported)577,610
Total Current Liabilities  (calculated)634,873
+/- 57,263
Long-term Liabilities
Long term Debt Total 117,821
Long term Debt 100,371
Capital Lease Obligations Min Short Term Debt-85,612
Long-term Liabilities Other 4
Long-term Liabilities  (as reported)140,187
Long-term Liabilities  (calculated)132,584
+/- 7,603
Total Stockholder Equity
Common Stock75,305
Retained Earnings 221,009
Total Stockholder Equity (as reported)296,314
Total Stockholder Equity (calculated)296,314
+/-0
Other
Capital Stock75,305
Cash And Equivalents22,764
Cash and Short Term Investments 22,764
Common Stock Shares Outstanding 7,531
Liabilities and Stockholders Equity 1,014,110
Net Debt 230,694
Net Invested Capital 527,037
Net Working Capital 165,428



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-31
> Total Assets 
150,000
152,491
347,408
505,446
557,003
630,236
746,486
839,161
911,398
1,014,110
1,014,110911,398839,161746,486630,236557,003505,446347,408152,491150,000
   > Total Current Assets 
73,000
64,681
268,609
403,970
426,285
472,890
564,946
608,274
676,135
743,342
743,342676,135608,274564,946472,890426,285403,970268,60964,68173,000
       Cash And Cash Equivalents 
3,000
2,515
2,634
6,504
8,828
16,163
15,259
14,266
16,383
29
2916,38314,26615,25916,1638,8286,5042,6342,5153,000
       Net Receivables 
25,000
20,927
154,072
245,463
284,823
274,301
347,134
369,335
451,211
555,790
555,790451,211369,335347,134274,301284,823245,463154,07220,92725,000
       Inventory 
31,000
30,368
92,803
107,449
113,242
134,687
164,679
177,520
146,500
100,337
100,337146,500177,520164,679134,687113,242107,44992,80330,36831,000
       Other Current Assets 
14,000
10,277
18,383
176
18,585
47,739
37,874
47,153
56,367
58,364
58,36456,36747,15337,87447,73918,58517618,38310,27714,000
   > Long-term Assets 
0
0
0
0
130,718
157,346
172,435
230,887
235,264
271,073
271,073235,264230,887172,435157,346130,7180000
       Property Plant Equipment 
0
78,944
76,931
99,228
128,850
155,218
170,163
227,431
231,924
267,411
267,411231,924227,431170,163155,218128,85099,22876,93178,9440
       Long Term Investments 
0
1
1
1
1
1
1
0
0
0
0001111110
       Other Assets 
0
8,865
1,867
2,247
1,867
2,127
2,271
3,456
3,338
3,356
3,3563,3383,4562,2712,1271,8672,2471,8678,8650
> Total Liabilities 
70,000
57,406
216,816
361,344
394,808
459,748
563,913
636,581
667,537
717,796
717,796667,537636,581563,913459,748394,808361,344216,81657,40670,000
   > Total Current Liabilities 
40,000
31,091
171,074
310,726
334,995
374,081
462,184
512,487
505,120
577,610
577,610505,120512,487462,184374,081334,995310,726171,07431,09140,000
       Short-term Debt 
24,000
24,168
84,822
115,587
113,335
115,372
130,016
149,117
135,887
85,612
85,612135,887149,117130,016115,372113,335115,58784,82224,16824,000
       Short Long Term Debt 
24,000
24,168
84,822
155,113
117,314
115,372
140,450
164,356
135,887
112,903
112,903135,887164,356140,450115,372117,314155,11384,82224,16824,000
       Accounts payable 
6,000
5,604
87,794
173,567
200,597
230,210
303,629
302,729
295,048
433,169
433,169295,048302,729303,629230,210200,597173,56787,7945,6046,000
       Other Current Liabilities 
26,000
23,949
27,869
13,731
13,827
13,183
12,759
40,210
14,773
3,189
3,18914,77340,21012,75913,18313,82713,73127,86923,94926,000
   > Long-term Liabilities 
0
0
0
0
59,812
85,012
101,729
124,094
162,417
140,187
140,187162,417124,094101,72985,01259,8120000
       Long term Debt Total 
0
0
0
39,174
43,857
65,996
80,121
111,636
144,898
117,821
117,821144,898111,63680,12165,99643,85739,174000
       Capital Lease Obligations 
0
0
0
0
394
441
0
0
0
0
00004413940000
       Other Liabilities 
0
2,148
9,315
11,444
15,955
19,671
12,503
12,458
0
0
0012,45812,50319,67115,95511,4449,3152,1480
> Total Stockholder Equity
0
95,085
130,592
144,102
162,195
170,488
182,573
202,581
243,861
296,314
296,314243,861202,581182,573170,488162,195144,102130,59295,0850
   Common Stock
182,000
75,305
75,305
75,305
75,305
75,305
75,305
75,305
75,305
75,305
75,30575,30575,30575,30575,30575,30575,30575,30575,305182,000
   Retained Earnings 
-109,000
-93,693
-58,186
68,797
-24,929
-16,636
-4,551
15,457
168,556
221,009
221,009168,55615,457-4,551-16,636-24,92968,797-58,186-93,693-109,000
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
7,154
7,154
7,154
5,500
5,500
5,500
5,500
0
0
005,5005,5005,5005,5007,1547,1547,1540



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue1,611,062
Cost of Revenue-1,304,555
Gross Profit306,507306,507
 
Operating Income (+$)
Gross Profit306,507
Operating Expense-1,515,128
Operating Income95,936-1,208,621
 
Operating Expense (+$)
Research Development2,884
Selling General Administrative50,653
Selling And Marketing Expenses-
Operating Expense1,515,12853,537
 
Net Interest Income (+$)
Interest Income16,796
Interest Expense-16,795
Net Interest Income-27,3891
 
Pretax Income (+$)
Operating Income95,936
Net Interest Income-27,389
Other Non-Operating Income Expenses-
Income Before Tax (EBT)70,20695,936
EBIT - interestExpense = -16,795
52,453
69,248
Interest Expense16,795
Earnings Before Interest and Taxes (ebit)-87,001
Earnings Before Interest and Taxes (ebitda)103,965
 
After tax Income (+$)
Income Before Tax70,206
Tax Provision-17,753
Net Income From Continuing Ops52,45352,453
Net Income52,453
Net Income Applicable To Common Shares52,453
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-27,389
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DODO.CC
now

I found you a STOCH Bearish Reversal Divergence on the daily chart of DODO.CC.

DODO.CC Daily Candlestick Chart
DKA.CC
1 minute ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of DKA.CC.

DKA.CC Daily Candlestick Chart
DIAMOND.CC
1 minute ago

I found you a RSI Bullish Reversal Divergence on the daily chart of DIAMOND.CC.

DIAMOND.CC Daily Candlestick Chart
DIA.CC
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DIA.CC.

DIA.CC Daily Candlestick Chart
DGP.CC
1 minute ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of DGP.CC.

DGP.CC Daily Candlestick Chart
DGC.CC
2 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of DGC.CC.

DGC.CC Daily Candlestick Chart
DEV.CC
2 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of DEV.CC.

DEV.CC Daily Candlestick Chart
CZRX.CC
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CZRX.CC.

CZRX.CC Daily Candlestick Chart
IPAXU.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IPAXU.NASDAQ.

IPAXU.NASDAQ Daily Candlestick Chart
CLT.CC
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CLT.CC.

CLT.CC Daily Candlestick Chart
CLB.CC
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CLB.CC.

CLB.CC Daily Candlestick Chart
CKB.CC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CKB.CC.

CKB.CC Daily Candlestick Chart
TR.V
1 hour ago

I found you a MACD Bullish Hidden Divergence on the daily chart of TR.V.

TR.V Daily Candlestick Chart
NIFLN0000.CM
1 hour ago

I found you a RSI Bullish Reversal Divergence on the daily chart of NIFLN0000.CM.

NIFLN0000.CM Daily Candlestick Chart
AUTON0000.CM
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of AUTON0000.CM.

AUTON0000.CM Daily Candlestick Chart
VONEN0000.CM
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VONEN0000.CM.

VONEN0000.CM Daily Candlestick Chart
MELE.BR
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MELE.BR.

MELE.BR Daily Candlestick Chart
REN.JSE
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of REN.JSE.

REN.JSE Daily Candlestick Chart
CEU.PSE
2 hours ago

I found you a Golden Cross on the daily chart of CEU.PSE.

CEU.PSE Daily Candlestick Chart
HKY.OL
2 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of HKY.OL.

HKY.OL Daily Candlestick Chart
SLF-PK.TO
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SLF-PK.TO.

SLF-PK.TO Daily Candlestick Chart
DECCANCE.NSE
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DECCANCE.NSE.

DECCANCE.NSE Daily Candlestick Chart
DECIPHER.BSE
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DECIPHER.BSE.

DECIPHER.BSE Daily Candlestick Chart
DECCANCE.BSE
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DECCANCE.BSE.

DECCANCE.BSE Daily Candlestick Chart